John Hollander

Personal Information
Title Associate Professor
Expertise Cardiovascular & Cardiomyopathy
Institution West Virginia University
Newsletter? Not signed up.
Data Summary
Grants/SubContracts 1
Progress Reports 1
Publications 3
Protocols 0
Committees 2

MicroRNA Regulation in the Type 2 Diabetic Human Heart
Diabetic cardiomyopathy is an impairment of heart muscle, characterized by metabolic disturbance and contractile dysfunction. The mitochondrion is central in the development of diabetic cardiomyopathy however, examination of mitochondria is complicated by the fact that two subpopulations are present in the cardiac myocyte, interfibrillar mitochondria (IFM) which situate between the contractile apparatus, and subsarcolemmal mitochondria (SSM), which exist beneath the plasma membrane. Research from our laboratory using a mouse model of type 2 diabetes mellitus (db/db) have revealed a robust dysfunctional profile particularly to cardiac SSM, as indicated by disruption of energetics and proteomic make-up. MicroRNAs (miRNA) are non-coding RNAs that have been shown to regulate protein expression of target mRNAs. Data from our laboratory indicates that miRNA profiles in the heart are dynamic following diabetic insult. Further, our results indicate that the mitochondrion possesses a pool of miRNAs that translocate into and out of the organelle in a dynamic fashion. Currently, it is unclear whether similar phenomena exist in type 2 diabetic human heart or whether miRNAs outside or within the mitochondrion are associated. The objectives of this application are: (1) to assess the impact of type 2 diabetes mellitus on cardiac transcriptome profiles in atrial appendage tissue from diagnosed type 2 diabetic patients and non-diabetic patients; and (2) to assess the impact of type 2 diabetes mellitus on cardiac mitochondrial subpopulation proteomes in atrial appendage tissue from diagnosed type 2 diabetic patients and non-diabetic patients. With respect to expected outcomes, the combination of work proposed in our discovery-based experiments will provide identification of transcriptomic and proteomic targets for therapeutic intervention in the type 2 diabetic human heart while validating the biological relevance of the db/db mouse model. The results will enable progression in this field by establishing the clinical applicability of mitochondrial subpopulation-based therapeutic examinations in the diabetic heart. The data from these experiments will be critical for our future NIH R01 grant application examining energetic abnormalities in the type 2 diabetic heart.

Progress Reports
Drag a column header and drop it here to group by that column
ApplicationComplete DateReportOptions
MicroRNA Regulation in the Type 2 Diabetic Human Heart (Hollander, John)
11/20/2014View Progress Report Document

Annual Reports
No uploaded documents found.

 PublicationAltmetricsSubmitted ByPubMed IDStatus

Year: 2017; Items: 1

Regulating MicroRNA Expression: At the Heart of Diabetes Mellitus and the Mitochondrion.
Hathaway QA, Pinti MV, Durr AJ, Waris S, Shepherd DL, Hollander JM
American journal of physiology. Heart and circulatory physiology, 2017, ajpheart.0

Year: 2015; Items: 2

Transgenic overexpression of mitofilin attenuates diabetes mellitus-associated cardiac and mitochondria dysfunction.
Thapa D, Nichols CE, Lewis SE, Shepherd DL, Jagannathan R, Croston TL, Tveter KJ, Holden AA, Baseler WA, Hollander JM
Journal of molecular and cellular cardiology, 2015 (79), 212 - 223
Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA (MitomiR) in the Diabetic Heart.
Jagannathan R, Thapa D, Nichols CE, Shepherd DL, Stricker JC, Croston TL, Baseler WA, Lewis SE, Martinez I, Hollander JM
Circulation. Cardiovascular genetics, 2015
No uploaded documents found.
No protocols found.
No records to display.